Switzerland: SHS makes first investment from sixth fund: €10m in Simulands
SHS, a Germany-based private equity provider investing in healthcare companies in Europe, has made the first investment from its sixth fund, which held a...
Bupa’s care division impacted by occupancy and workforce challenges
Underlying losses in aged care at Bupa grew year on year as challenges in the UK, Australia and New Zealand impacted performance in the...
B Capital closes inaugural healthcare fund at US$500m
B Capital, a global multi-stage investment firm, has closed the inaugural B Capital Healthcare Fund I, which, in conjunction with B Capital Growth Fund...
Israel: Teva upsizes and prices SLNs to fund bond tender
Teva Pharmaceutical Industries has upsized its planned US$2.06bn offering of sustainability linked notes (SLN) and priced approximately US$2.49bn (equivalent) of senior notes as part...
Singapore: Aslan Pharma raises US$20m from a PP with potential to raise another US$80m
Nasdaq listed Aslan Pharmaceuticals, a clinical-stage immunology-focused biopharmaceutical company, with teams in California and Singapore, has raised approximately US$20m in a private placement to...
Financing round-up: HBOX Therapies, Resalis Therapeutics, Eluminex Biosciences, Angiodroid, VisionHealth
Germany: VisionHealth, a digital therapeutics company focused on enhancing inhaled treatment of chronic lung diseases, has closed a €3m pre-series A financing led by...
Australia: Kazia completes equity financing round
Kazia Therapeutics, an oncology-focused drug development company, has concluded an equity financing round totalling A$7.106m (US$4.78m) split A$4.5m raised from existing sophisticated and institutional...
Japan: Secondary follow-on of Amvis Holdings to raise JPY34.2bn
Two shareholders of Amvis Holdings, a fast-growing operator of hospice-type, disability nursing facilities, are selling 10 million shares to raise JPY34.2bn (US$255.1m) through a...
Israel: Teva to issue SLNs to fund tender offer
Teva Pharmaceutical Industries, a global leader in generic and innovative medicines, is issuing US$2.06bn (equivalent) of euro-denominated and US dollar-denominated sustainability-linked notes. Teva is...
Spex Capital launches €100m fund for early stage healthtech ventures
Digital health and med-tech investment firm Spex Capital has launched a new fund with a target size of €100m.
The Spex Venture HealthTech Fund is a closed-end...
©2023 All rights reserved LaingBuisson 
